Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |
| Name of reporting entity or other means of identification |
Captor Therapeutics
|
| Domicile of entity |
w Polsce
|
| Legal form of entity |
S.A.
|
| Address of entity's registered office |
ul. Duńska 11, 54-427 Wrocław
|
| Description of nature of entity's operations and principal activities |
Przeważający przedmiot działalności Jednostki dominującej to badania naukowe i prace rozwojowe w dziedzinie biotechnologii (72.11.Z).
|
| Disclosure of material accounting policy information [text block] |
13.
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
47.
|